New York: Moderna has reported that its COVID-19 vaccine candidate is producing antibodies in older adults similar to levels in their younger counterparts. The side effects produced are roughly the ...
Pune: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday raised some serious concerns regarding the production and distribution of COVID-19 vaccine in the country. Poonawalla asked whether the ...
Beijing: SinoVac, one of the leading coronavirus vaccine candidates, is ready to launch its vaccine by early 2021 for the world, including United States. SinoVac CEO Yin Weidong has promised ...
Geneva: The World Health Organisation (WHO) cannot guarantee that a COVID-19 vaccine would actually work. “We have no guarantee that any single vaccine now in development will work,” the head ...
Pune: The Serum Institute of India (SII) will start the third and final phase of human trial of Oxford-Astrazeneca’s coronavirus vaccine at Pune’s Sasson General Hospital early next week. “The ...
London: The World Health Organisation (WHO) has warned of "alarming rates of transmission" of COVID-19 cases across Europe, pointing out that the number of cases in September "should serve as ...
Washington: US President Donald Trump has raised hopes again by stating that the FDA could approve a vaccine against COVID-19 within 3 to 4 weeks. “The previous administration would have ...
Washington: Microsoft co-founder Bill Gates on Tuesday said that India is a leading vaccine producer and may release huge volumes of COVID-19 vaccine by 2021. According to a PTI report, ...
Beijing: One of the coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Centre for ...
Even if a coronavirus vaccine is developed successfully by early next year, there won’t be enough to administer all global citizens till the end of 2024, Serum Institute of India’s ...
Copyright © 2024 Frontier Media
